These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 21531994
1. Live birth chances in women with extremely low-serum anti-Mullerian hormone levels. Weghofer A, Dietrich W, Barad DH, Gleicher N. Hum Reprod; 2011 Jul; 26(7):1905-9. PubMed ID: 21531994 [Abstract] [Full Text] [Related]
2. Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Gleicher N, Weghofer A, Barad DH. Fertil Steril; 2010 Dec; 94(7):2824-7. PubMed ID: 20538269 [Abstract] [Full Text] [Related]
3. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization. Lukaszuk K, Kunicki M, Liss J, Lukaszuk M, Jakiel G. Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092 [Abstract] [Full Text] [Related]
4. Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy. Nelson SM, Yates RW, Fleming R. Hum Reprod; 2007 Sep; 22(9):2414-21. PubMed ID: 17636277 [Abstract] [Full Text] [Related]
5. Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology. Lukaszuk K, Liss J, Kunicki M, Jakiel G, Wasniewski T, Woclawek-Potocka I, Pastuszek E. Reprod Biol; 2014 Sep; 14(3):176-81. PubMed ID: 25152514 [Abstract] [Full Text] [Related]
6. Probability of live birth in women with extremely low anti-Müllerian hormone concentrations. Lukaszuk K, Kunicki M, Liss J, Bednarowska A, Jakiel G. Reprod Biomed Online; 2014 Jan; 28(1):64-9. PubMed ID: 24268729 [Abstract] [Full Text] [Related]
7. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?]. Grzegorczyk-Martin V, Khrouf M, Bringer-Deutsch S, Mayenga JM, Kulski O, Cohen-Bacrie P, Benaim JL, Belaisch-Allart J. Gynecol Obstet Fertil; 2012 Jan; 40(7-8):411-8. PubMed ID: 22521986 [Abstract] [Full Text] [Related]
8. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment. Peñarrubia J, Fábregues F, Manau D, Creus M, Casals G, Casamitjana R, Carmona F, Vanrell JA, Balasch J. Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015 [Abstract] [Full Text] [Related]
9. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos. Majumder K, Gelbaya TA, Laing I, Nardo LG. Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579 [Abstract] [Full Text] [Related]
10. Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles. Tal R, Seifer DB, Khanimov M, Schwartz E, Grazi RV, Malter HE. Reprod Biomed Online; 2013 Apr; 26(4):360-7. PubMed ID: 23419793 [Abstract] [Full Text] [Related]
11. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P. Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354 [Abstract] [Full Text] [Related]
12. The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization. Reijnders IF, Nelen WL, IntHout J, van Herwaarden AE, Braat DD, Fleischer K. Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():45-50. PubMed ID: 26967346 [Abstract] [Full Text] [Related]
13. The association between anti-Müllerian hormone and IVF pregnancy outcomes is influenced by age. Wang JG, Douglas NC, Nakhuda GS, Choi JM, Park SJ, Thornton MH, Guarnaccia MM, Sauer MV. Reprod Biomed Online; 2010 Dec; 21(6):757-61. PubMed ID: 21044868 [Abstract] [Full Text] [Related]
14. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Abdalla H, Thum MY. Hum Reprod; 2004 Apr; 19(4):893-8. PubMed ID: 15016786 [Abstract] [Full Text] [Related]
15. Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction. Brodin T, Hadziosmanovic N, Berglund L, Olovsson M, Holte J. J Clin Endocrinol Metab; 2013 Mar; 98(3):1107-14. PubMed ID: 23408576 [Abstract] [Full Text] [Related]
16. Effects of anti-Müllerian hormone and follicle stimulating hormone levels on in vitro fertilization pregnancy rate. Chen YP, Wu WH, Wu HM, Chen CK, Wang HS, Huang HY. Taiwan J Obstet Gynecol; 2014 Sep; 53(3):313-6. PubMed ID: 25286783 [Abstract] [Full Text] [Related]
17. Using anti-Müllerian hormone to identify a good prognosis group in women of advanced reproductive age. Fridén B, Sjöblom P, Menezes J. Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):411-5. PubMed ID: 21988118 [Abstract] [Full Text] [Related]
18. Cumulative live-birth rates after in vitro fertilization. Malizia BA, Hacker MR, Penzias AS. N Engl J Med; 2009 Jan 15; 360(3):236-43. PubMed ID: 19144939 [Abstract] [Full Text] [Related]
19. Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction. La Marca A, Nelson SM, Sighinolfi G, Manno M, Baraldi E, Roli L, Xella S, Marsella T, Tagliasacchi D, D'Amico R, Volpe A. Reprod Biomed Online; 2011 Apr 15; 22(4):341-9. PubMed ID: 21317041 [Abstract] [Full Text] [Related]
20. Anti-müllerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-müllerian hormone is modest. Alson SSE, Bungum LJ, Giwercman A, Henic E. Eur J Obstet Gynecol Reprod Biol; 2018 Jun 15; 225():199-204. PubMed ID: 29738982 [Abstract] [Full Text] [Related] Page: [Next] [New Search]